Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
What exactly is a disease? Amid ongoing debate over whether obesity should be classified as a disease, two experts examine what a disease is – and who gets to decide.
Have the benefits of statins been overstated? Researcher Paula Byrne writes on what she and her colleagues learned from a meta-analysis of 21 clinical trials involving 140,000 patients.
Children and consent for medical treatment All adult patients in Australia are presumed to be competent to provide consent to their own treatment. But can children and young people give consent?
Government flags shift in fee-for-service model Minister says reforms will involve every health professional ‘working to their scope of practice’, while RACGP stresses importance of GP stewardship.
Chance of early flu season in 2023 With the pandemic causing unpredictable changes in influenza patterns, the Northern Hemisphere may provide insight on the months ahead.
Is the soaring use of ADHD stimulants a cause for concern? Prescriptions for some medications have increased by nearly 4450% in just two years, but experts are divided on whether this signifies long-due relief for patients or a potential for harm.
$2.2 billion Medicare investment ‘just what the doctor ordered’ Rebuilding general practice was a key focus of National Cabinet, which introduced a number of measures to make healthcare more accessible and affordable.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
Tighten Paxlovid eligibility: PBAC advice The committee that looks at PBS listings has recommended the first-line COVID-19 treatment be limited to the highest risk patients aged 50–69 years.